Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Inger Marie Saga"'
Impact of the Serogroup A Meningococcal Conjugate Vaccine, MenAfriVac, on Carriage and Herd Immunity
Autor:
Absatou Ky Ba, Marie-Pierre Préziosi, Stacey W. Martin, Paul A. Kristiansen, Inger Marie Saga, Mamoudou Harouna Djingarey, Abdoul Salam Ouedraogo, Jennifer Dolan Thomas, Fabien Diomandé, Lassana Sangaré, Flavien Aké, Rasmata Ouédraogo, Sylvestre R. M. Tiendrebéogo, Thomas A. Clark, Denis Kandolo, Nancy E. Messonnier, Lara K. Misegades, F. Marc LaForce, Musa Hassan-King, Dominique A. Caugant, Idrissa Sanou
Publikováno v:
Clinical Infectious Diseases. 56:354-363
Background The conjugate vaccine against serogroup A Neisseria meningitidis (NmA), MenAfriVac, was first introduced in mass vaccination campaigns of 1-29-year-olds in Burkina Faso in 2010. It is not known whether MenAfriVac has an impact on NmA carri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::27465e02a5cbadb4bcd989c73d62726e
https://doi.org/10.1093/cid/cis892
https://doi.org/10.1093/cid/cis892
Autor:
Paul A, Kristiansen, Absatou Ky, Ba, Abdoul-Salam, Ouédraogo, Idrissa, Sanou, Rasmata, Ouédraogo, Lassana, Sangaré, Fabien, Diomandé, Denis, Kandolo, Inger Marie, Saga, Lara, Misegades, Thomas A, Clark, Marie-Pierre, Préziosi, Dominique A, Caugant
Publikováno v:
BMC Infectious Diseases
Background The conjugate vaccine against serogroup A Neisseria meningitidis (NmA), MenAfriVac, is currently being introduced throughout the African meningitis belt. In repeated multicentre cross-sectional studies in Burkina Faso we demonstrated a sig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4c37350340bd55c39568883c1580b202
https://pubmed.ncbi.nlm.nih.gov/25472422
https://pubmed.ncbi.nlm.nih.gov/25472422